OncoDiscover: Real-Time Monitoring of Cancer Through CTCs
OncoDiscover® is a patented, DCGI-approved blood test designed to detect and monitor circulating tumor cells (CTCs) in real time. Built
OneCell Diagnostics is now 1Cell.Ai
OneCell Diagnostics is now 1Cell.Ai
OncoDiscover® is a patented, DCGI-approved blood test designed to detect and monitor circulating tumor cells (CTCs) in real time. Built
OncoIndx is a first-in-class comprehensive genomic profiling solution developed by OneCell Diagnostics. It leverages next-generation sequencing (NGS) to analyze over
Join us as we look back on an incredible gathering of scientists, clinicians, and innovators shaping the future of cancer
Watch Now: Aravindan Vasudevan – Decoding the ‘Perfect Villain’ of Cancer Capturing cancer cells-Uncovering secrets for treatments | Aravindan Vasudevan
Published in Journal of Clinical Oncology, 2022 | Abstract #3019, ASCO This study showcases the use of artificial intelligence (AI)
3rd Indian Cancer Congress 2023 Scientific Session: Driving Innovation in Genomic Profiling and Liquid Biopsy Join leading experts as they
Published in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2022 This study investigates the role of circulating tumor
Watch Now: Dr. Gowhar Shafi at Indian Cancer Congress 2023 Artificial Intelligence Redefining Patient Eligibility for Immunotherapy Hear from Dr.
Watch Now: Mohan Uttarwar at Indian Cancer Congress 2023 AI to Democratize the Adaptation of Precision Oncology: Augmented Intelligence for
Pioneering the Future of Translational Cancer Research At AACR 2024, 1Cell.Ai showcased how AI, live-cell analytics, and multi-omics platforms are